ALA-guided fluorescence cystoscopy is already widely used, and in March 2005 HAL was approved in Europe for the diagnosis of bladder cancer. The approval process continues in the US. Technical ...

The current gold standard for the diagnosis of bladder cancer is cystoscopy, an invasive endoscopic procedure that allows doctors to examine the lining of the bladder and the urethra. The ...

Cystoscopy is the reference standard for bladder cancer detection, and is also used to monitor patients with a history of the disease. The procedure is, however, invasive, and some patients find ...

Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...

Improved detection rates with fluorescence cystoscopy lead to better management of patients with non-muscle-invasive bladder cancer The use of ALA fluorescence cystoscopy to diagnose and treat ...

Bladder cancer is diagnosed by cystoscopy, a procedure in which the urologist passes a lighted telescope through the urethra into the bladder and looks directly at the inside lining of these ...

Consequently, when using Blue Light Cystoscopy with Cysview, bladder cancer management decisions can be made more appropriately. The poster presentation (Abstract No. 686, Poster Session B ...

James: Adding an MRI post-flexible cystoscopy improved decision-making and accelerated time to correct treatment considerably for the worst muscle-invasive bladder cancer cases, without ...

OSLO, Norway, March 14, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the study "Oncologic Outcomes of Blue Light Cystoscopy in an Equal ...